Lords Mark Industries Ltd. (KRATOSENER) — Tipsheet

Lords Mark opens IVD plant two months early, expands capacity by 70%

Tipsheet Editorial — Tue, 23 Jun 2026 16:21:33 GMT

The ₹67-cr nano-cap is moving beyond NBFC into diagnostics with a new Vasai facility and plans for cancer detection and AI-enabled devices.

What’s new

Commissioned 14,000 sq. ft. IVD unit at Vasai, two months ahead of schedule.
Total operational space expands from 20,000 to 34,000 sq. ft.
Plans for cancer detection facility (2029) and AI-enabled medical device plant.

Why it matters

For a company with a ₹67-cr market cap but ₹491-cr quarterly sales, the capacity expansion signals a strategic pivot from NBFC to high-margin diagnostics. The early launch and product portfolio (56 ELISA kits) strengthen the growth narrative, though no revenue impact is quantified yet.

What we’re watching

Revenue contribution from IVD sales in coming quarters.
Progress on the cancer detection facility and AI-enabled plant.
Whether diagnostics EBITDA margins exceed those of the NBFC business.

The full read

Lords Mark Industries, a nano-cap with a ₹67-crore market cap but surprising scale (₹491 crore quarterly sales), has commissioned a 14,000 sq. ft. IVD manufacturing unit at Vasai two months ahead of schedule. The facility boosts total operational space by 70% to 34,000 sq. ft. and will produce 56 ELISA test kits and rapid diagnostics. The R&D wing is dedicated to the late Ratan Tata. Further plans include a cancer detection facility (named after Dr. A.P.J. Abdul Kalam) by January 2029 and a long-term vision for an AI-enabled medical device plant. For a company that generated ₹684.7 crore in FY26 revenue, this expansion is a material step into high-margin diagnostics. The pace at which this new business shifts the revenue mix will determine the real impact.

Primary source: BSE · NSE

Lords Mark clears legal hurdle to listing with ₹16.25 cr warrant conversion

Tipsheet Editorial — Mon, 08 Jun 2026 11:28:06 GMT

Bennett Coleman's petition was withdrawn after Lords Mark acknowledged its obligation. The company will now issue shares to clear the path to listing.

What’s new

Delhi High Court dismissed BCCL's petition after Lords Mark agreed to issue shares under a warrant subscription agreement.
Lords Mark will issue 10,28,483 equity shares to Bennett Coleman at ₹158 per share.
The resolution removes legal uncertainty ahead of the company's planned listing.

Why it matters

This is a binding resolution, not a preliminary step. For a nano-cap company, issuing ₹16.25 crore worth of equity (about 24% of its ₹67 crore market cap) is a material capital event. Clearing the legal overhang removes the last listed obstacle to its trading debut.

What we’re watching

Confirmation that the 10,28,483 shares have been issued within the court-ordered three-day window.
The post-conversion share capital structure and any impact on promoter holding.
The timeline for the commencement of trading.

The full read

Lords Mark Industries settled the legal fight that threatened its listing. The Delhi High Court dismissed Bennett Coleman's petition after the company agreed to convert five warrants and issue 10,28,483 shares at ₹158 apiece. The deal is worth ₹16.25 crore. For a company with a ₹67 crore market cap, that is a 24% dilutive event. The shares are to be issued within three days of the court order. This was the main piece of legal uncertainty hanging over the company's planned listing. With the petition withdrawn, the obligation is now binding and final. There are no further conditional steps.

Primary source: BSE · NSE

Lords Mark's first full-year result shows ₹684.7 cr revenue on ₹67 cr market cap

Tipsheet Editorial — Sat, 30 May 2026 13:56:55 GMT

A nano-cap just posted ₹52.8 crore in standalone profit. Q4 revenue tripled sequentially, but the filing doesn't explain why.

What’s new

Lords Mark reported ₹684.7 crore in consolidated revenue for FY26, the first full year after amalgamating five subsidiaries.
Standalone revenue in Q4 jumped to ₹441.9 crore from ₹150.2 crore in Q3.
Standalone net profit for the year was ₹52.8 crore; the board skipped a dividend.

Why it matters

The numbers give the first clean read on the amalgamated entity's scale. At a market cap of ₹67 crore, the ₹52.8 crore profit implies a P/E multiple well below 2x. The Q4 surge suggests much of the consolidated revenue was back-loaded into the final quarter, which is the first question any buyer of this stock needs answered.

What we’re watching

Whether the Q4 standalone run-rate holds into FY27 or reflects timing of subsidiary consolidation.
How the ₹67 crore market cap re-rates once the consolidation dust settles.
Any disclosure explaining the near-tripling of standalone revenue in Q4.

The full read

Lords Mark Industries is a ₹67 crore market-cap company that just posted ₹684.7 crore in consolidated revenue and ₹52.8 crore in standalone profit. Those are the first full-year numbers since it folded five subsidiaries into one entity. The headline shift is the scale. At a sub-2x P/E, the stock looks priced for a company half this size, which means either the market hasn't caught up or it's discounting something the filing doesn't address. Q4 is the puzzle. Standalone revenue jumped from ₹150.2 crore to ₹441.9 crore in a single quarter. Whether that's a genuine run-rate or the timing of consolidation closing, the filing doesn't say. The auditors signed off without qualifications. No dividend. The number that matters isn't the ₹684.7 crore — it's the ₹67 crore market cap staring back at it.

Primary source: BSE · NSE